| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 905.103 | 613.700 | 613.888 | - | - | - | - | - | - | - |
| Total Income - EUR | 1.006.279 | 633.657 | 614.494 | - | - | - | - | - | - | - |
| Total Expenses - EUR | 954.938 | 665.875 | 605.466 | - | - | - | - | - | - | - |
| Gross Profit/Loss - EUR | 51.341 | -32.218 | 9.028 | - | - | - | - | - | - | - |
| Net Profit/Loss - EUR | 43.307 | -32.218 | 6.642 | - | - | - | - | - | - | - |
| Employees | 7 | 9 | 10 | - | - | - | - | - | - | - |
Check the financial reports for the company - Colvimed Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 314.879 | 300.167 | 285.923 | - | - | - | - | - | - | - |
| Current Assets | 591.477 | 493.110 | 380.924 | - | - | - | - | - | - | - |
| Inventories | 326.357 | 318.674 | 100.789 | - | - | - | - | - | - | - |
| Receivables | 209.157 | 153.244 | 270.889 | - | - | - | - | - | - | - |
| Cash | 55.962 | 21.191 | 9.246 | - | - | - | - | - | - | - |
| Shareholders Funds | 201.685 | 167.410 | 171.220 | - | - | - | - | - | - | - |
| Social Capital | 100.272 | 99.250 | 97.570 | - | - | - | - | - | - | - |
| Debts | 704.670 | 625.866 | 495.626 | - | - | - | - | - | - | - |
| Income in Advance | 0 | 0 | 0 | - | - | - | - | - | - | - |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4773 - 4773" | |||||||||
| CAEN Financial Year |
4773
|
|||||||||
Comments - Colvimed Srl